Chemical & Pharmaceutical Research
Open AccessEvaluation of Imidapril Degradation Kinetics in Aqueous Solution
Authors: Chika J Mbah, Philip F Uzor, Chinwe M Onah, Chinwe N Oha.
Abstract
Imidapril is a dipeptide-type, dicarboxylate-containing, non-sulfhydryl angiotensin converting enzyme inhibitor clinically employed in the treatment of essential hypertension, chronic congestive heart failure, and type 1 diabetic nephropathy. The purpose was to investigate imidapril degradation kinetics under acidic and alkaline hydrolysis. The degradation kinetics was carried out in various pH solutions (pH 1.00 – 10.00); ionic strength solutions (0.10 - 0.50), buffer solutions (0.05M - 0.20M) and temperatures 323 – 353 degrees Kelvin. High performance liquid chromatography met.hod was utilized in the kinetic degradation analysis. The method was considered to be accurate, precise, specific and linear over the concentration range of 1- 6 µg/ml. The degradation reaction was observed to follow apparent first-order rate kinetics and the rate constants for the decomposition were obtained from plots of logarithm percent drug concentration remaining versus time. The degradation was specific hydrogen ion and hydroxide ion catalyzed reactions respectively. Calculated activation energies were 65.22 and 59.46 kJ/mol for acidic (pH 1.04) and alkaline (pH 10.02) hydrolysis respectively. In conclusion, imidapril degradation kinetics occurred under acidic and alkaline conditions and followed apparent first-order rate kinetics.
Editor-in-Chief
View full editorial board →